Login / Signup

Artificial Intelligence in Community-Based Diabetic Retinopathy Telemedicine Screening in Urban China: Cost-effectiveness and Cost-Utility Analyses With Real-world Data.

Senlin LinYingyan MaYi XuLina LuJiangnan HeJianfeng ZhuYajun PengTao YuNathan CongdonHai-Dong Zou
Published in: JMIR public health and surveillance (2023)
Our study may provide a reference for policy making in planning community-based telemedicine screening for DR in LMICs. Our findings indicate that unless the referral compliance of patients with suspected DR increases, the adoption of the AI model may not improve the value of telemedicine screening compared to that of manual grading in LMICs. The main reason is that in the context of the low labor costs in LMICs, the direct health care costs saved by replacing manual grading with AI are less, and the screening effectiveness (QALYs and years without blindness) decreases. Our study suggests that the magnitude of the value generated by this technology replacement depends primarily on 2 aspects. The first is the extent of direct health care costs reduced by AI, and the second is the change in health care service utilization caused by AI. Therefore, our research can also provide analytical ideas for other health care sectors in their decision to use AI.
Keyphrases
  • artificial intelligence
  • healthcare
  • big data
  • machine learning
  • diabetic retinopathy
  • deep learning
  • systematic review
  • public health
  • liquid chromatography